Published in Mediators Inflamm on November 20, 2013
Does tight control of systemic factors help in the management ofdiabetic retinopathy? Indian J Ophthalmol (2016) 0.99
Current concepts in diabetic retinopathy. Diabetes Metab J (2014) 0.84
Network Based Approach in the Establishment of the Relationship between Type 2 Diabetes Mellitus and Its Complications at the Molecular Level Coupled with Molecular Docking Mechanism. Biomed Res Int (2016) 0.75
Body mass index and risk of diabetic retinopathy: A meta-analysis and systematic review. Medicine (Baltimore) (2017) 0.75
Enhanced Oxidative Stress and Other Potential Biomarkers for Retinopathy in Type 2 Diabetics: Beneficial Effects of the Nutraceutic Supplements. Biomed Res Int (2015) 0.75
Body mass index and retinopathy in type 1 diabetic patients. Int J Endocrinol (2014) 0.75
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 34.34
Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract (2009) 25.83
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med (2004) 17.91
Obesity. Lancet (2005) 17.67
Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med (1999) 16.57
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med (1994) 16.24
2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens (2003) 11.32
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med (2000) 10.05
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet (2010) 9.20
Mechanisms linking obesity with cardiovascular disease. Nature (2006) 9.07
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care (1992) 7.69
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol (1984) 7.68
Biological action of leptin as an angiogenic factor. Science (1998) 6.02
The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care (2005) 5.80
The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med (1993) 5.61
Diagnosis and classification of diabetes mellitus. Diabetes Care (2007) 4.78
UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia (2001) 4.78
A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem (1983) 4.39
The 14-year incidence of visual loss in a diabetic population. Ophthalmology (1998) 4.08
Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol (2004) 3.38
The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil (2010) 3.20
United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol (1998) 2.93
Ten-year incidence of visual loss in a diabetic population. Ophthalmology (1994) 2.91
Obesity: the worldwide epidemic. Clin Dermatol (2004) 2.82
Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol (2003) 2.74
Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye (Lond) (2004) 2.54
United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med (1996) 2.41
The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care (2003) 2.33
Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia (1995) 2.27
Perspectives on diabetic retinopathy. Am J Ophthalmol (2003) 2.22
Obesity and eye diseases. Surv Ophthalmol (2007) 2.13
Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care (2001) 2.11
Angiogenic factors are elevated in overweight and obese individuals. Int J Obes (Lond) (2005) 2.05
The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study. Ophthalmology (2002) 1.73
Obesity: epidemiology and clinical aspects. Best Pract Res Clin Gastroenterol (2004) 1.71
Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne) (2013) 1.62
Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Diabetologia (2009) 1.59
Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. Invest Ophthalmol Vis Sci (2004) 1.56
Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia (2003) 1.44
Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med (1997) 1.35
Mortality risk by body weight and weight change in people with NIDDM. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetes Care (1995) 1.26
The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care (2003) 1.25
Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nat Clin Pract Nephrol (2007) 1.22
Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences. Neth J Med (2013) 1.20
C-reactive protein, body mass index, and diabetic retinopathy. Invest Ophthalmol Vis Sci (2010) 1.14
Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol (1998) 1.12
Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators Inflamm (2013) 1.11
Association of obesity with diabetic retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS Report no. 8). Acta Diabetol (2009) 1.11
Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Invest Ophthalmol Vis Sci (2011) 1.07
Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group. Diabetes Care (1996) 1.05
The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy. Coll Antropol (2013) 1.02
Impact of overweight on chronic microvascular complications in type 1 diabetic patients. Diabetes Care (2005) 1.00
Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese Type 2 diabetic subjects. Diabet Med (2004) 0.95
Risk factors of developing proliferative retinopathy in type 1 diabetic patients : role of BMI. Diabetes Care (2002) 0.91
Treatment of obesity hypertension and diabetes syndrome. Hypertension (2001) 0.90
Prevalence and incidence of retinopathy in elderly diabetic patients receiving early diagnosis and treatment. Exp Ther Med (2013) 0.87
Obesity--a risk factor for diabetic retinopathy in type 2 diabetes? Coll Antropol (2005) 0.87
Evaluation of accuracy of 20 different test kits for the enzymic determination of cholesterol. Clin Chem (1983) 0.86
Overweight and obesity: an overview of prevalence, clinical impact, and economic impact. Dis Manag (2004) 0.85
Is leptin associated with diabetic retinopathy? Diabetes Care (2000) 0.85
Strategies for preventing type 2 diabetes: an update for clinicians. Ther Adv Chronic Dis (2013) 0.83
Maternal immune system adaptation to pregnancy--a potential influence on the course of diabetic retinopathy. Reprod Biol Endocrinol (2010) 0.80
Moderate changes in weight and physical activity can prevent or delay the development of type 2 diabetes mellitus in susceptible individuals. Nutr Rev (2003) 0.78
The KID Study VI: diabetic complications and associated diseases in younger type 2 diabetics still performing a profession. Prevalence and correlation with duration of diabetic state, BMI and C-peptide. Exp Clin Endocrinol Diabetes (1999) 0.78
Adiponectin is independently associated with glycosylated haemoglobin. Eur J Endocrinol (2004) 0.77
Inflammation and pharmacological treatment in diabetic retinopathy. Mediators Inflamm (2013) 1.00
Diagnostic procedures and management of dry eye. Biomed Res Int (2013) 0.91
Inflammation, haemostatic disturbance, and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes. Mediators Inflamm (2013) 0.89
Body mass index and retinopathy in type 1 diabetic patients. Int J Endocrinol (2014) 0.75